{"id":"https://openalex.org/W4394601718","doi":"https://doi.org/10.1212/wnl.0000000000205317","title":"Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Anti-nerve Growth Factor (NGF) Antibody Tanezumab in Subjects with Moderate to Severe Pain Due to Schwannomatosis (P6-13.001)","display_name":"Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Anti-nerve Growth Factor (NGF) Antibody Tanezumab in Subjects with Moderate to Severe Pain Due to Schwannomatosis (P6-13.001)","publication_year":2024,"publication_date":"2024-04-09","ids":{"openalex":"https://openalex.org/W4394601718","doi":"https://doi.org/10.1212/wnl.0000000000205317"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000205317","doi":"https://doi.org/10.1212/wnl.0000000000205317","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.0000000000205317","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031152645","display_name":"Danielle Silverman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Silverman","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091567557","display_name":"Jennifer Da","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Da","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061307417","display_name":"Vanessa L. Merker","orcid":"https://orcid.org/0000-0002-4542-5227","observed_orcids":["https://orcid.org/0000-0002-4542-5227"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vanessa Merker","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014329627","display_name":"Ina Ly","orcid":"https://orcid.org/0000-0003-0494-2946","observed_orcids":["https://orcid.org/0000-0003-0494-2946"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ina Ly","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013091949","display_name":"Alona Muzikansky","orcid":"https://orcid.org/0000-0001-7585-8181","observed_orcids":["https://orcid.org/0000-0001-7585-8181"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alona Muzikansky","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020641478","display_name":"Michael W. Parsons","orcid":"https://orcid.org/0000-0001-8619-9564","observed_orcids":["https://orcid.org/0000-0001-8619-9564"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Parsons","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065611220","display_name":"Pamela L. Wolters","orcid":"https://orcid.org/0000-0001-9319-6281","observed_orcids":["https://orcid.org/0000-0001-9319-6281"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela Wolters","raw_affiliation_strings":["National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101506362","display_name":"Lei Xu","orcid":"https://orcid.org/0000-0003-0525-183X","observed_orcids":["https://orcid.org/0000-0003-0525-183X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Xu","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020554337","display_name":"M. Brown","orcid":"https://orcid.org/0000-0002-8310-4774","observed_orcids":["https://orcid.org/0000-0002-8310-4774"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Brown","raw_affiliation_strings":["Pfizer Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076650143","display_name":"Mehrdad Haghpassand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehrdad Haghpassand","raw_affiliation_strings":["Pfizer Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059222419","display_name":"Justin T. Jordan","orcid":"https://orcid.org/0000-0001-6198-817X","observed_orcids":["https://orcid.org/0000-0001-6198-817X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Jordan","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059797681","display_name":"Scott Randall Plotkin","orcid":"https://orcid.org/0000-0002-6109-6419","observed_orcids":["https://orcid.org/0000-0002-6109-6419"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Plotkin","raw_affiliation_strings":["Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05937874,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"102","issue":"17_supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.48410001397132874,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.48410001397132874,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.45170000195503235,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tanezumab","display_name":"tanezumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.875},{"id":"https://openalex.org/keywords/schwannomatosis","display_name":"schwannomatosis","score":0.9700000286102295},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.8080000281333923},{"id":"https://openalex.org/keywords/analgesic-efficacy","display_name":"analgesic efficacy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/anti-ngf-antibody","display_name":"anti-NGF antibody","score":0.878000020980835},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7720026969909668},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.6504485607147217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6198899745941162},{"id":"https://openalex.org/C2778423431","wikidata":"https://www.wikidata.org/wiki/Q417782","display_name":"Nerve growth factor","level":3,"score":0.5825645327568054},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38764846324920654},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.364448606967926},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13099810481071472},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000205317","doi":"https://doi.org/10.1212/wnl.0000000000205317","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.0000000000205317","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388588600","https://openalex.org/W4293217060","https://openalex.org/W1997383797","https://openalex.org/W1982879446","https://openalex.org/W2899202662","https://openalex.org/W7132826551","https://openalex.org/W1975659610","https://openalex.org/W2236055221","https://openalex.org/W2060485806","https://openalex.org/W2091349116"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"assess":[2,298],"the":[3,187,209,217,223,234,242,248,285,351,596,615,635,654,674,694,713,732,751,771,790,890,1008,1027,1045],"analgesic":[4],"efficacy":[5],"of":[6,86,320,334,353,368,380,391,397,441,470,496,508,526,528,534,546,554,566,574,586,598,617,637,656,676,696,715,734,753,773,792,821,837,848,857,861,892,1010,1029,1047,1100,1111],"subcutaneous":[7],"tanezumab":[8,110,121,193,265],"10":[9,111,122],"mg":[10,112,123],"in":[11,45,142,201,208,216,226,251,288,350,437,502,513,595,614,634,653,673,693,712,731,750,770,789,806,813,826,832,889,1007,1026,1044,1066,1073,1080],"subjects":[12,65,167],"with":[13,68,106,262,361,906,919,943,964,990],"schwannomatosis":[14,260],"(SWN)-related":[15],"pain,":[16,264],"administered":[17],"alongside":[18],"any":[19],"pre-existing":[20],"non-NSAID":[21],"therapy.":[22],"Background:":[23],"Schwannomatosis":[24],"is":[25,295,926,947,968,994],"a":[26,57,103,157,358,406,427,603,622,642,661,681,701,720,739,758,778,797,877,897,912,916,936,940,957,961,978,982,1015,1034,1052,1121],"rare":[27],"neurogenetic":[28],"condition":[29],"characterized":[30],"by":[31,119],"multiple":[32],"schwannomas":[33,47],"and":[34,91,97,131,151,155,194,212,237,987],"severe":[35],"chronic":[36],"pain.":[37,61,304],"Elevated":[38],"nerve":[39],"growth":[40],"factor":[41],"(NGF)":[42],"levels":[43],"identified":[44],"painful":[46],"prompted":[48],"our":[49],"study":[50,101],"on":[51,548,1051],"tanezumab,":[52],"an":[53,289,378,468,479,494,524,544,564,584],"anti-NGF":[54],"antibody,":[55],"as":[56,357,377,467,493,523,543,563,583,602,621,641,660,680,700,719,738,757,777,796,896,915,939,960,981,1014,1033],"treatment":[58,125],"for":[59,128,233,241,301,355,375,465,491,521,541,561,581,600,605,619,624,639,644,658,663,678,683,698,703,717,722,736,741,755,760,775,780,794,799,894,899,922,1012,1017,1031,1036,1049,1060],"SWN-related":[60,70,303],"Design/Methods:":[62],"We":[63,138],"enrolled":[64],"(\u226518":[66],"years)":[67],"moderate-to-severe":[69,263],"pain":[71,88,143,267],"intensity":[72,144],"[Numerical":[73],"Rating":[74],"Scale":[75],"(NRS-11)":[76],"score":[77,181,203,253],"\u22655,":[78],"range:":[79,171],"0\u201310":[80],"(no":[81],"pain-worst":[82],"pain)]":[83],"despite":[84],"use":[85],"neuropathic":[87],"medications,":[89],"NSAIDS,":[90],"opioids;":[92],"able":[93],"to":[94,109,161,297,310,316,411,418,430,457,880,928,949,970,996,1126],"discontinue":[95],"NSAIDS;":[96],"without":[98,136],"osteoarthritis.":[99],"The":[100,177,198,318,332,439,814,835,846,859],"included":[102],"double-blind":[104,188],"period":[105],"patients":[107,191,261],"randomized":[108],"SQ":[113,124],"or":[114,408,478,931,952,973,999,1055,1123],"placebo":[115],"(days":[116,126,134],"1\u201356),":[117],"followed":[118],"unblinded":[120,221],"57\u2013112)":[127],"all":[129],"patients,":[130],"safety":[132,246],"follow-up":[133],"113\u2013281)":[135],"treatment.":[137],"measured":[139],"weekly":[140],"changes":[141,271],"from":[145,327,341,389,405,426,448,482,844,855,868,876,1088,1098,1108,1120],"Baseline-Day":[146],"57,":[147],"Day":[148,152],"57-Day":[149],"113,":[150],"113-Day":[153],"169":[154],"performed":[156],"one-tailed":[158],"t-test":[159],"(p<0.05)":[160],"evaluate":[162],"tanezumab\u2019s":[163,299],"efficacy.":[164],"Results:":[165],"9":[166],"(median":[168],"age:":[169],"44,":[170],"33\u201365,":[172],"7":[173],"females)":[174],"were":[175,229],"enrolled.":[176],"mean":[178,199,224,249],"baseline":[179],"NRS-11":[180,202,227,252],"was":[182,204,254,904],"7.6":[183],"(SD":[184,206,214,231,239,256],"2.1).":[185],"During":[186,220,245],"period,":[189],"4":[190],"received":[192,196,324,338,347,372,386,401,423,445,462,476,488,518,538,558,578,592,611,631,650,670,690,709,728,747,767,786,841,852,865,873,886,1004,1023,1041,1085,1095,1105,1116],"5":[195],"placebo.":[197],"change":[200,225,250],"\u22122.5":[205],"4.5)":[207],"tanezumab/tanezumab":[210,235],"group":[211,236],"\u22120.4":[213],"2.1)":[215],"placebo/tanezumab":[218,243],"group.":[219,244],"treatment,":[222],"scores":[228],"0":[230],"0)":[232],"\u22121.4":[238],"1.9)":[240],"follow-up,":[247],"0.8":[255],"1.6).":[257],"Conclusions:":[258],"Among":[259],"reduced":[266],"intensity;":[268],"although":[269],"these":[270],"reflect":[272],"clinically":[273],"meaningful":[274],"differences":[275],"(2":[276],"points),":[277],"they":[278],"lacked":[279],"statistical":[280],"significance.":[281],"Limited":[282],"enrollment":[283],"during":[284],"pandemic":[286],"resulted":[287],"underpowered":[290],"study.":[291],"A":[292],"larger":[293],"trial":[294],"needed":[296],"potential":[300,900],"treating":[302],"Disclosure:":[305],"Ms.":[306],"Silverman":[307],"has":[308,314,323,337,346,371,385,400,416,422,435,444,455,461,475,487,500,511,517,537,557,577,591,610,630,649,669,689,708,727,746,766,785,804,811,824,830,840,851,864,872,885,911,935,956,977,1003,1022,1040,1064,1071,1078,1084,1094,1104,1115],"nothing":[309,315,417,456],"disclose.":[311,317,419,458],"Jennifer":[312],"Da":[313],"institution":[319,333,440,836,847,860],"Vanessa":[321,335,344],"Merker":[322,336,345],"research":[325,339,387,446,842,853,866,1086,1096,1106],"support":[326,340,388,447,843,854,867,1087,1097,1107],"Children's":[328,684,1089],"tumor":[329],"foundation":[330],".":[331],"NF":[342],"Northeast.":[343],"personal":[348,373,463,489,519,539,559,579,593,612,632,651,671,691,710,729,748,768,787,887,1005,1024,1042],"compensation":[349,374,464,490,520,540,560,580,594,613,633,652,672,692,711,730,749,769,788,888,1006,1025,1043],"range":[352,597,616,636,655,675,695,714,733,752,772,791,891,1009,1028,1046],"$10,000-$49,999":[354,599,677,716,1048],"serving":[356,376,466,492,522,542,562,582,601,620,640,659,679,699,718,737,756,776,795,895,1013,1032,1050],"science":[359],"writer":[360],"Neurofibromatosis":[362,449,944,991],"Network.":[363],"An":[364,393,504,530,550,570,817],"immediate":[365,394,505,531,551,571,818],"family":[366,395,506,532,552,572,819],"member":[367,396,507,533,553,573,820,918,942,963,989],"Dr.":[369,383,398,420,433,442,453,459,473,515,535,555,575,589,608,628,647,667,687,706,725,744,764,783,802,809,822,828,838,849,862,870,883,909,933,954,975,1001,1020,1038,1062,1069,1076,1082,1092,1102,1113],"Ly":[370,384,399],"employee":[379,469,495,525,545,565,585],"Enanta":[381],"Pharmaceuticals.":[382,743],"Department":[390,856,1099],"Defense.":[392,858,1101],"intellectual":[402,1117],"property":[403,1118],"interests":[404,930,951,972,998,1119],"discovery":[407,1122],"technology":[409,1124],"relating":[410,429,879,1125],"health":[412,431,881,1127],"care.":[413,432,882,1128],"Alona":[414],"Muzikansky":[415],"Parsons":[421],"publishing":[424,874],"royalties":[425,875],"publication":[428,878],"Wolters":[434,443],"stock":[436,477,501,512,805,812,825,831,1065,1072,1079],"Bristol-Myers-Squibb.":[438],"Therapeutic":[450],"Acceleration":[451],"Program.":[452],"Xu":[454],"Brown":[460,474],"Pfizer":[471,483],"Inc.":[472,484,627],"ownership":[480],"interest":[481],"Mr.":[485,498,509],"Haghpassand":[486,499,510],"Pfizer.":[497,503],"Merck.":[514],"Jordan":[516,536,556,576,590,609,629,648,668,688,707,726,745,765,784,803,810,823,829,839,850,863,871,884,910,934,955,976],"City":[527],"Beverly.":[529],"Dietitians":[547],"Demand.":[549],"Genesis":[567],"HR":[568],"Solutions.":[569],"Harborlight":[587],"Montesorri.":[588],"Consultant":[604,623,643,662,682,702,721,740,759,779,798,1016,1035],"Navio":[606,807],"Theragnostics.":[607,808],"$500-$4,999":[618,638,657,697,735,754,774,793,893],"Recursion":[625],"Pharmaceuticals,":[626],"CEC":[645],"Oncology.":[646],"Texas":[664],"Health":[665],"Resources.":[666],"Tumor":[685,1090],"Foundation.":[686,1091],"BCD":[704],"Meetings.":[705],"Shepherd":[723],"Therapeutics.":[724,801,1019,1068,1075],"Alexion":[742],"Michigan":[761],"State":[762],"University.":[763],"Akeila":[781,833],"Bio.":[782,834],"Springworks":[800],"Doctor":[815],"Lounge.":[816],"OldGate.":[827],"NIH.":[845],"PCORI.":[869],"Reimbursement":[898],"consultant":[901],"role":[902],"that":[903,925,946,967,993],"aborted":[905],"Magnet":[907],"Biomedicine.":[908],"non-compensated":[913,937,958,979],"relationship":[914,938,959,980],"board":[917,941,962,986,988,1059],"United":[920],"Council":[921],"Neurologic":[923],"Subspecialties":[924],"relevant":[927,948,969,995],"AAN":[929,950,971,997],"activities.":[932,953,974,1000],"Northeast":[945],"ABA":[965],"Academy":[966],"chair,":[983],"scientific":[984],"advisory":[985],"Network":[992],"Plotkin":[1002,1021,1039,1063,1070,1077,1083,1093,1103,1114],"$5,000-$9,999":[1011,1030],"NFlection":[1018,1067],"Akouos.":[1037],"Scientific":[1053],"Advisory":[1054],"Data":[1056],"Safety":[1057],"Monitoring":[1058],"SonALAsense.":[1061,1081],"NF2":[1074],"National":[1109],"Institutes":[1110],"Health.":[1112]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-04-10T00:00:00"}